3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-D]ピリミジン-4-アミン

3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-D]ピリミジン-4-アミン 化学構造式
330786-24-8
CAS番号.
330786-24-8
化学名:
3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-D]ピリミジン-4-アミン
别名:
3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-D]ピリミジン-4-アミン
英語名:
3-(4-Phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine
英語别名:
3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-4-aMine;4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidine;ibrutinib N-2;Ibrutinib INT1;Ilutinib impurity 8;Ibrutinib Impurity 8;Ibrutinib Impurity 46;3-d]pyriMidin-4-ylaMine;Ibrutinib intermediate 2;Ibrutinib intermeidate N-2
CBNumber:
CB72648137
化学式:
C17H13N5O
分子量:
303.32
MOL File:
330786-24-8.mol

3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-D]ピリミジン-4-アミン 物理性質

融点 :
>262oC (dec.)
沸点 :
577.4±50.0 °C(Predicted)
比重(密度) :
1.380±0.06 g/cm3(Predicted)
貯蔵温度 :
Keep in dark place,Inert atmosphere,Room temperature
溶解性:
DMSO(微量)、エタノール(微量)
酸解離定数(Pka):
10.40±0.30(Predicted)
外見 :
個体
色:
ペールブラウンからブラウン
InChI:
InChI=1S/C17H13N5O/c18-16-14-15(21-22-17(14)20-10-19-16)11-6-8-13(9-7-11)23-12-4-2-1-3-5-12/h1-10H,(H3,18,19,20,21,22)
InChIKey:
YYVUOZULIDAKRN-UHFFFAOYSA-N
SMILES:
C1=NC(N)=C2C(C3=CC=C(OC4=CC=CC=C4)C=C3)=NNC2=N1
安全性情報
  • リスクと安全性に関する声明
  • 危険有害性情報のコード(GHS)
絵表示(GHS) GHS hazard pictograms
注意喚起語 警告
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード
H302 飲み込むと有害 急性毒性、経口 4 警告 GHS hazard pictograms P264, P270, P301+P312, P330, P501
H315 皮膚刺激 皮膚腐食性/刺激性 2 警告 GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 強い眼刺激 眼に対する重篤な損傷性/眼刺激 性 2A 警告 GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 呼吸器への刺激のおそれ 特定標的臓器毒性、単回暴露; 気道刺激性 3 警告 GHS hazard pictograms
注意書き
P261 粉じん/煙/ガス/ミスト/蒸気/スプレーの吸入を避ける こと。
P305+P351+P338 眼に入った場合:水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。

3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-D]ピリミジン-4-アミン 価格 もっと(9)

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入
富士フイルム和光純薬株式会社(wako) W01COBQE-9112 3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-d]ピリミジン-4-アミン
3-(4-Phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine
330786-24-8 1g ¥10000 2024-03-01 購入
富士フイルム和光純薬株式会社(wako) W01COBQE-9112 3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-d]ピリミジン-4-アミン
3-(4-Phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine
330786-24-8 5g ¥10000 2024-03-01 購入
富士フイルム和光純薬株式会社(wako) W01COBQE-9112 3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-d]ピリミジン-4-アミン
3-(4-Phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine
330786-24-8 25g ¥22500 2024-03-01 購入
富士フイルム和光純薬株式会社(wako) W01COBQE-9112 3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-d]ピリミジン-4-アミン
3-(4-Phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine
330786-24-8 100g ¥80000 2024-03-01 購入
富士フイルム和光純薬株式会社(wako) W01FLC462627 3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-d]ピリミジン-4-アミン
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
330786-24-8 1g ¥8100 2021-03-23 購入

3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-D]ピリミジン-4-アミン 化学特性,用途語,生産方法

説明

5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine, also known as ibrutinib N-2, is a light brown solid. It can be prepared from 3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine and 4-phenoxybenzeneboronicacid by Suzuki coupling reaction[1]. Ibrutinib N-2 is often used in the preparation of the marketed drug PCI-32765 (IMBRUVICAVR)[2]. PCI-32765 is aIbrutinib -BTK inhibitor and can be used as an anticancer drug to treat B cell cancers like mantle cell lymphoma and chronic lymphocytic leukemia.

使用

As Ibrutinib intermediates, 5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine can be used as organic synthesis intermediates and pharmaceutical intermediates, mainly used in laboratory research and development and chemical production processes.

主な応用

3-(4-Phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine is an intermediate for the synthesis of ibrutinib, which is mainly used in drug synthesis and related experimental studies.

合成

説明図
2 g of 3-iodo-4-aminopyrazolo[3,4-d]pyrimidine (7.7 mmol),3.28 g p-phenoxybenzeneboronic acid (15.4 mmol)And 5.28 g of K3PO4 (23.0 mmol) were dissolved in 25 mL of dioxane and 10 mL of water.After stirring for 5-8 minutes, argon gas was passed for 20 minutes.An additional 1.4 g of tetrakis(triphenylphosphine)palladium (1.2 mmol) was added.After heating again for 10 minutes, the heating was started, and the reaction was carried out at 120 ?? C for 24 hours.After the reaction was completed, it was cooled to room temperature, stirred for 24 hours to wait for product to precipitate, and the reaction mixture was washed with 25 mL of water and filtered.The filtered solid was again washed with 75 ml of methanol, washed with 50 mL of ethanol, and dried in a dry box.There was obtained 1.75 g of 3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine-4-amine in a yield of 75%.

参考文献

[1] Rampalli, S, et al. Process for the Preparation of Ibrutinib. PCT Int. Appl. 2017; 134588.
[2] Dasar G, et al. One-step synthesis of magnetically recyclable palladium loaded magnesium ferrite nanoparticles: application in synthesis of anticancer drug PCI-32765. Inorganic and Nano-Metal Chemistry, 2020; 50.

3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-D]ピリミジン-4-アミン 上流と下流の製品情報

原材料

準備製品


3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-D]ピリミジン-4-アミン 生産企業

Global( 425)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
SyncoZymes (Shanghai) Co., Ltd.,
+86-021-68187180-811 +86-13681683526
lchen@syncozymes.com China 188 58
Changzhou uniringchem Co., Ltd.
+undefined13585446801
sales@uniringchem.com China 68 58
Henan Fengda Chemical Co., Ltd
+86-371-86557731 +86-13613820652
info@fdachem.com China 16805 58
hebei hongtan Biotechnology Co., Ltd
+86-86-1913198-3935 +8617331935328
sales03@chemcn.cn China 951 58
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806
sales@capotchem.com China 29797 60
Shanghai Daken Advanced Materials Co.,Ltd
+86-371-66670886
info@dakenam.com China 15932 58
Beijing Cooperate Pharmaceutical Co.,Ltd
010-60279497
sales01@cooperate-pharm.com CHINA 1811 55
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21691 55
Hangzhou FandaChem Co.,Ltd.
008657128800458; +8615858145714
fandachem@gmail.com China 9347 55
Shanghai Yingrui Biopharma Co., Ltd.
+86-21-33585366 - 03@
sales03@shyrchem.com CHINA 738 60

3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-D]ピリミジン-4-アミン  スペクトルデータ(1HNMR)


330786-24-8(3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-D]ピリミジン-4-アミン)キーワード:


  • 330786-24-8
  • 2) 3-(4-PHENOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE
  • ibrutinib N-2
  • 1H-Pyrazolo[3,4-d]pyriMidin-4-aMine, 3-(4-phenoxyphenyl)-
  • Ibrutinib intermeidate N-2
  • Ibrutinib INT1
  • Ibrutinib Impurity 8
  • -(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine
  • PCI-32765 (IBRUTINIB) INTERMEDIATE(N-2)
  • 5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylamine (N-2)
  • 5-(3-Phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
  • 5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine
  • 5-(4-Phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
  • 5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-y
  • 3-d]pyriMidin-4-ylaMine
  • 5-(4-phenoxyphenyl)-7H-pyrrolo[2
  • 3-(4-phenoxyphenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-amine
  • Ibrutinib impurity 3/ 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine/Ibrutinib impurity
  • 3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidine
  • Ibrutinib intermediates N-2
  • 3-(4-phenoxyphenyl)-1 H- pyrazolium [3,4- D] pyrimidine-4-amine
  • Ibrutinib deacryloylpiperidine
  • Ibrutinib N-Despiperidinyl Impurity
  • 5- (4-phenoxyphenyl) -7H-pyrrolio [2,3-d] pyrimidin-4-ylamine
  • Ibrutinib intermediate 2
  • 5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINE/3-(4-PHENOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE
  • 5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine ISO 9001:2015 REACH
  • IbrutinibintermeidChemicalbookateN-2
  • 3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-4-aMine
  • 4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidine
  • 3-(4-フェノキシフェニル)-1H-ピラゾロ[3,4-D]ピリミジン-4-アミン
Copyright 2017 © ChemicalBook. All rights reserved